PHILADELPHIA, PA — Latus Bio is advancing experimental gene therapies for Huntington’s disease and CLN2 Batten disease while developing delivery technology intended to improve how genetic treatments reach…

PHILADELPHIA, PA — Latus Bio is advancing experimental gene therapies for Huntington’s disease and CLN2 Batten disease while developing delivery technology intended to improve how genetic treatments reach brain, spinal …

Source disclosure

This is a source-linked briefing. Read the original report from Mychesco .